Faculty

Sascha Dublin

Affiliate Professor, Epidemiology

206-287-2870

Education

PhD Epidemiology, University of Washington, 1999
MD University of Washington, 2001

Contact

206-287-2870

Kaiser Permanente Washington Health Research Institute
1730 Minor Avenue, Suite 1600
Seattle, WA 98101

Research Interests

Dr. Dublin’s research interests include pharmacoepidemiology, pregnancy outcomes and perinatal epidemiology; aging; and cardiovascular epidemiology. Her work uses real-world health care data from Group Health and many other sources to better understand the safety and effectiveness of medications and other medical interventions.  She often focuses on the impact of interventions in vulnerable populations, particularly pregnant women and older adults. She also has interest and expertise in using novel statistical and epidemiologic methods to answer real-world questions, such as the use of two-phase study designs to reduce bias and Natural Language Processing  to extract information from electronic medical records (EMRs).  She is the Group Health site Principal Investigator for the Medication Exposures in Pregnancy Risk Evaluation Program (MEPREP), a multisite collaboration that has developed data sets including 1.2 million pregnancies across 11 health plans to examine medication safety in pregnant women.

Recent Publications (PubMed)

Evaluating the role of metabolic surgery versus GLP1 agonists in patients living with obesity and chronic kidney disease - a systematic review.
(2026 Oct 25)
Surgeon
Davey MG, Heneghan HM, Corcelles R

ctDNA clearance and outcomes for resectable lung cancer from NeoCOAST-2.
(2026 Oct 25)
Nature
McGrath L, Kar G, Bonanno L, Guisier F, Insa A, Liberman M, Bylicki O, Livi L, Egenod T, Corre R, Kim DW, Garcia Campelo MR, Provencio Pulla M, Shim BY, Metro G, Bennouna J, Bielska AA, Yohannes AR, Shaju J, He Y, Dowson A, Grenga I, Spicer J, Forde PM, Cascone T

Final prespecified analysis of the phase 3 LITESPARK-011 study: belzutifan plus lenvatinib versus cabozantinib for advanced renal cell carcinoma after anti-PD-(L)1 therapy.
(2026 Oct 25)
Ann Oncol
Heng DYC, Schmidinger M, McDermott R, Park SH, Burotto M, Ciccarese C, Verzoni E, Suárez C, Eto M, Cutuli HJ, Porta C, Kopp RM, Rottey S, de Velasco G, Valderrama BP, Azad AA, De Giorgi U, Pavic M, Tomczak P, Figlin R, Westgeest HM, Guida A, Necchi A, Schutz FA, Suelmann BBM, Haanen JB, Lin J, Perini RF, Vickery D, Motzer RJ, LITESPARK-011 Investigators

Sestrins as Multifunctional Regulators of Cell Viability on the Pathways from Stress to Aging.
(2026 Oct)
Biochemistry (Mosc) 91(10): 1891-1906
Haidurov A, Budanov AV

What is the impact of diabetic foot ulcers on an individual's health-related quality of life? A systematic review.
(2026 Oct 23)
J Tissue Viability 35(4): 101074
Alaradi M, Strachan K, Tawash E, Matrook K, Muhammad S, Weatherall T, Patton D, Moore Z, Avsar P

Show complete publication list

In the News